Brighton Jones LLC Ampio Pharmaceuticals, Inc. Transaction History

Brighton Jones LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	BUY	$1.21 - $1.8 $240,251 - $357,399	198,555 Added 116.48%	369,011 $613,000
Q2 2021 Aug 10, 2021	SELL	$1.56 - $1.98 $309,745 - $393,138	-198,555 Reduced 53.81%	170,456 $285,000
Q1 2021 May 07, 2021	SELL	$1.36 - $2.49 $40,665 - $74,453	-29,901 Reduced 7.5%	369,011 $624,000
Q4 2020 Feb 10, 2021	BUY	$0.75 - $2.76 $37,500 - $138,000	50,000 Added 14.33%	398,912 $634,000
Q3 2020 Nov 12, 2020	BUY	$0.61 - $1.17 $91,107 - $174,747	149,357 Added 74.85%	348,912 $334,000
Q2 2020 Aug 11, 2020	BUY	$0.47 - $0.72 $260 - $399	555 Added 0.28%	199,555 $127,000
Q1 2020 May 13, 2020	BUY	$0.36 - $0.74 $15,476 - $31,812	42,990 Added 27.56%	199,000 $83,000
Q4 2019 Feb 07, 2020	BUY	$0.35 - $0.58 $19,409 - $32,163	55,455 Added 55.15%	156,010 $91,000
Q3 2018 Nov 07, 2018	BUY	$0.44 - $3.02 $6,600 - $45,300	15,000 Added 17.53%	100,555 $51,000
Q1 2018 May 03, 2018	BUY	$2.16 - $3.48 $118,800 - $191,400	55,000 Added 180.0%	85,555 $291,000
Q2 2017 Aug 08, 2017	BUY	N/A	30,555	30,555 $16,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.